Insider Transactions in Q2 2023 at Azitra Inc (AZTR)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 21
2023
|
Bayer Healthcare LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
1,307,401
+50.0%
|
-
|
|
Jun 21
2023
|
Andrew Mc Clary Director |
BUY
Conversion of derivative security
|
Indirect |
59,322
+50.0%
|
-
|
|
Jun 21
2023
|
Aaron G.L. Fletcher > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
4,354,871
+35.22%
|
-
|
|
Jun 21
2023
|
Aaron G.L. Fletcher > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
2,297,490
+35.35%
|
$11,487,450
$5.0 P/Share
|
|
Jun 21
2023
|
Aaron G.L. Fletcher > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
669,317
-100.0%
|
-
|
|
Jun 21
2023
|
Leslie W. Kreis > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
4,354,871
+35.22%
|
-
|
|
Jun 21
2023
|
Leslie W. Kreis > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
2,297,490
+35.35%
|
$11,487,450
$5.0 P/Share
|
|
Jun 21
2023
|
Leslie W. Kreis > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
669,317
-100.0%
|
-
|
|
Jun 21
2023
|
Francisco D. Salva President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+50.0%
|
$25,000
$5.0 P/Share
|
|
Jun 21
2023
|
Travis Whitfill Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
250
+50.0%
|
$1,250
$5.0 P/Share
|